Michael Bromberg, MD, PhD, talks with Physician’s Weekly about renal disease in patients with paroxysmal nocturnal ...

Spherix Global Insights recently released its latest findings from RealTime Dynamix™: Paroxysmal Nocturnal Hemoglobinuria Q1 2025 (US) an independent tracking study based on insights from 51 U.S.

Several lines of evidence support this mechanism. (1) PNH is closely related to aplastic anemia (AA). (2) PIGA mutant microclones exist in normal people but they do not expand. (3) In PNH patients ...

EMPAVELI's unique mechanism of targeting C3 broadens its applicability beyond PNH, including other complement-driven diseases like geographic atrophy and immune complex-mediated diseases. With ...

China has become the first country in the world to approve Roche’s anti-complement C5 antibody crovalimab, the only treatment for the rare disorder paroxysmal nocturnal haemoglobinuria (PNH ...

Apellis Pharma and partner Sobi have won EU approval for their paroxysmal nocturnal haemoglobinuria (PNH) drug pegcetacoplan in Europe, with a more restricted label than in the US. The European ...

I am 71, and I recently saw my urologist for urinating a lot and not getting enough sleep. He performed a flow test and a ...

BACKGROUND: Both unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH) are approved for venous thromboembolism (VTE) prophylaxis. Which agent is superior remains controversial ...

Read more about CAD comorbidities Testing for other common causes of hemolytic anemia was negative. He was treated with glucocorticoids, but he experienced hypoxic respiratory failure and septic shock ...

Among the other 189 patients, more than half (51.3% – 97 patients) did not have cytopenia while (48.7% – 92 patients) had only mild anemia, i.e. hemoglobin levels between 8 and 10 g/dL. A total of 175 ...